导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.36% | 335/826 |
| 近一周 | -0.07% | 242/874 |
| 近一月 | -8.03% | 794/873 |
| 近一季 | 13.88% | 63/865 |
| 近半年 | 3.81% | 283/845 |
| 近一年 | -12.50% | 609/802 |
| 近两年 | 24.56% | 569/736 |
| 近三年 | 2.94% | 504/659 |
| 成立以来 | 75.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.79% 206/1070 |
-0.37% 702/1101 |
- - |
- - |
| 2025 | 8.57% 839/1065 |
7.42% 256/1014 |
6.98% 195/1038 |
12.78% 788/1050 |
-16.22% 996/1065 |
| 2024 | -11.23% 787/1011 |
-10.94% 795/960 |
-2.61% 474/983 |
11.00% 548/991 |
-7.79% 813/1011 |
| 2023 | -17.54% 613/952 |
-4.21% 781/880 |
-9.54% 752/895 |
-4.45% 264/915 |
-0.39% 140/952 |
| 2022 | -29.41% 613/867 |
-14.57% 236/773 |
-0.58% 708/806 |
-22.83% 783/845 |
7.70% 120/867 |
| 2021 | -7.86% 459/740 |
-2.46% 241/580 |
25.94% 75/659 |
-12.03% 557/704 |
-14.74% 679/740 |
| 2020 | 99.09% 34/554 |
16.51% 17/419 |
52.72% 1/466 |
-1.02% 430/517 |
13.04% 250/554 |
| 2019 | 82.95% 4/410 |
31.96% 264/1146 |
10.27% 16/1228 |
18.85% 19/390 |
5.78% 320/410 |
| 2018 | -18.12% 50/349 |
- - |
7.84% 9/990 |
-16.82% 958/1000 |
-15.52% 894/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 广发医疗保健股票A VS. 东吴新产业精选股票A(580008) |